wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q33404024-36B85912-BEE3-488A-A1CA-AD5F5E35E53A
Q33404024-36B85912-BEE3-488A-A1CA-AD5F5E35E53A
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33404024-36B85912-BEE3-488A-A1CA-AD5F5E35E53A
PR-104 a bioreductive pre-prodrug combined with gemcitabine or docetaxel in a phase Ib study of patients with advanced solid tumours
P2860
Q33404024-36B85912-BEE3-488A-A1CA-AD5F5E35E53A
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33404024-36B85912-BEE3-488A-A1CA-AD5F5E35E53A
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
c279e1bcb0ca46b02d1fbc1dbe0f9b3680a6914e
P2860
A phase I trial of PR-104, a pre-prodrug of the bioreductive prodrug PR-104A, given weekly to solid tumour patients.